Inactive Instrument

Shanghai Pharmaceuticals Holding Co., Ltd Stock Other OTC

Equities

SHPMY

US81943R1005

Pharmaceuticals

Financials

Sales 2024 * 288B 39.62B 54.28B Sales 2025 * 317B 43.68B 59.84B Capitalization 62.6B 8.61B 11.8B
Net income 2024 * 4.97B 684M 936M Net income 2025 * 5.6B 771M 1.06B EV / Sales 2024 * 0.28 x
Net Debt 2024 * 18.42B 2.53B 3.47B Net Debt 2025 * 19.41B 2.67B 3.66B EV / Sales 2025 * 0.26 x
P/E ratio 2024 *
14 x
P/E ratio 2025 *
12.4 x
Employees -
Yield 2024 *
2.81%
Yield 2025 *
3.18%
Free-Float 38.5%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
President 54 19-06-26
President 51 13-06-04
Investor Relations Contact 35 15-12-31
Members of the board TitleAgeSince
President 51 13-06-04
President 54 19-06-26
Director/Board Member 67 19-06-26
More insiders
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.
Calendar
More about the company